Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000087 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 1, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
225,000
Total Value
$7,472,484.48
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 75,000 | $7.80 | $585,000.00 | 1,000,580 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale | 6,604 | $90.79 | $599,556.03 | 993,976 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale | 63,596 | $91.90 | $5,844,237.09 | 930,380 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale | 4,800 | $92.44 | $443,691.36 | 925,580 | Direct | โ | View Details | |
Director | Employee Warrant (right to buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 75,000 | $0.00 | $0.00 | 1,553,513 | Direct | โ | View Details |